Novel Sunitinib Strategy in Metastatic Renal Cell Carcinoma on Hemodialysis: Intermittent Dose of Sunitinib after Hemodialysis

The proper dose and schedule of sunitinib have yet to be established for patients with metastatic renal cell carcinoma (RCC) on hemodialysis. We reviewed two patients with metastatic RCC on hemodialysis who had been treated with sunitinib in Yonsei Cancer Center, Yonsei University College of Medicin...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Yoon, Sang Hyun, Kim, Ki Hyang, Choi, Junjeong, Kim, Gun Min, Kim, Joo Hoon, Kim, Hyo Song, Park, Young Nyun, Rha, Sun Young
格式: Artigo
語言:Inglês
出版: Korean Cancer Association 2010
主題:
Case Report
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC2953783/
https://ncbi.nlm.nih.gov/pubmed/20948925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2010.42.3.180
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍